These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 39062881)

  • 1. Multi-Omics Characterization of E3 Regulatory Patterns in Different Cancer Types.
    Li Z; Wan J; Li S; Tang Y; Lin YC; Ni J; Cai X; Yu J; Huang HD; Lee TY
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling.
    Yang Y; Hao X; Zhang J; Gao T; Huo M; Liu W; Hu T; Ma T; Yuan B; Zhang M; Teng X; Yu H; Huang W; Wang Y
    Cancer Lett; 2024 Sep; 600():217157. PubMed ID: 39127340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
    Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
    Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics integration highlights the role of ubiquitination in endometriosis fibrosis.
    Yang M; Jiang H; Ding X; Zhang L; Zhang H; Chen J; Li L; He X; Huang Z; Chen Q
    J Transl Med; 2024 May; 22(1):445. PubMed ID: 38735939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
    Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
    Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.
    Xie CM; Wei W; Sun Y
    J Genet Genomics; 2013 Mar; 40(3):97-106. PubMed ID: 23522382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
    Masumoto K; Kitagawa M
    Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis.
    Ji F; Zhou M; Sun Z; Jiang Z; Zhu H; Xie Z; Ouyang X; Zhang L; Li L
    Cancer Commun (Lond); 2021 Oct; 41(10):1007-1023. PubMed ID: 34196494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E3 ubiquitin ligase TRIM31: A potential therapeutic target.
    Deng NH; Tian Z; Zou YJ; Quan SB
    Biomed Pharmacother; 2024 Jul; 176():116846. PubMed ID: 38850648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM proteins and diseases.
    Watanabe M; Hatakeyama S
    J Biochem; 2017 Feb; 161(2):135-144. PubMed ID: 28069866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis.
    Venuto S; Merla G
    Cells; 2019 May; 8(5):. PubMed ID: 31137886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
    Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
    Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy.
    Sampson C; Wang Q; Otkur W; Zhao H; Lu Y; Liu X; Piao HL
    Clin Transl Med; 2023 Mar; 13(3):e1204. PubMed ID: 36881608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HECT-Type E3 Ubiquitin Ligases in Cancer.
    Bernassola F; Chillemi G; Melino G
    Trends Biochem Sci; 2019 Dec; 44(12):1057-1075. PubMed ID: 31610939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitination, Biotech Startups, and the Future of TRIM Family Proteins: A TRIM-Endous Opportunity.
    Bhaduri U; Merla G
    Cells; 2021 Apr; 10(5):. PubMed ID: 33923045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
    Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
    J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin ligases and medulloblastoma: genetic markers of the four consensus subgroups identified through transcriptome datasets.
    Vriend J; Rastegar M
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165839. PubMed ID: 32445667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E3 ubiquitin ligase-mediated regulation of bone formation and tumorigenesis.
    Sévère N; Dieudonné FX; Marie PJ
    Cell Death Dis; 2013 Jan; 4(1):e463. PubMed ID: 23328670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
    Liu L; Wong CC; Gong B; Yu J
    Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
    Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
    Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.